Temporal expression of fumonisin B1-induced tumor necrosis factor-α and interferon γ in mice

被引:9
作者
Bhandari, N
Enongene, EN
Riley, RT
Meredith, FI
Sharma, RP [1 ]
机构
[1] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA
[2] ARS, Mycotoxin Res Unit, USDA, Athens, GA 30604 USA
来源
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY | 2002年 / 131卷 / 02期
关键词
fumonisin; interferon gamma (IFN gamma); liver; mice; oral; subcutaneous; tumor necrosis factor-alpha (TNF alpha); toxicity;
D O I
10.1016/S1532-0456(01)00280-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fumonisin B-1 (FB1), a toxic metabolite of Fusarium verticillio ides, is a carcinogen and causative agent of various animal diseases. Our previous studies indicated the involvement of tumor necrosis factor-alpha (TNFalpha) in FB1-induced toxic responses. To further investigate the time-course of TNFalpha production and signaling mice (four/group) were treated subcutaneously (s.c.) or per os. (p.o.) with either vehicle or 25 mg/kg of FB1 as a single dose and sacrificed at 0, 2, 4, 8, 12 and 24 h after treatment. The TNFalpha expression was increased in liver and kidney after both routes of FB1 exposure without any alterations in spleen. The p.o.-route FB1 treatment caused greater hepatotoxicity compared to the s.c. route, as depicted by increased alanine aminotransferase and aspartate aminotransferase level in plasma, observed only after p.o. FB1 treatment. The increase in enzymes at 8 h after p.o. treatment correlated with the highest TNFalpha expression, also noted at 8 h after p.o. treatment, thus further confirming the involvement of TNFalpha in FB1 toxicity. The interferon (IFN)-gamma expression was increased in liver at 4 h after p.o. FB1 treatment, suggesting a possible combined role of TNFalpha and IFNgamma in their induction and hepatotoxicity. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:113 / 122
页数:10
相关论文
共 49 条
[1]   Tumor necrosis factor-α mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression [J].
Baxter, GT ;
Kuo, RC ;
Jupp, OJ ;
Vandenabeele, P ;
MacEwan, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) :9539-9547
[2]   TUMOR NECROSIS, CACHEXIA, SHOCK, AND INFLAMMATION - A COMMON MEDIATOR [J].
BEUTLER, B ;
CERAMI, A .
ANNUAL REVIEW OF BIOCHEMISTRY, 1988, 57 :505-518
[3]   Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice [J].
Bhandari, N ;
He, QR ;
Sharma, RP .
TOXICOLOGY, 2001, 165 (2-3) :195-204
[4]   ROLE OF PROINFLAMMATORY CYTOKINES IN ACETAMINOPHEN HEPATOTOXICITY [J].
BLAZKA, ME ;
WILMER, JL ;
HOLLADAY, SD ;
WILSON, RE ;
LUSTER, MI .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 133 (01) :43-52
[5]   Characterization of cell-cycle arrest by fumonisin B1 in CV-1 cells [J].
Ciacci-Zanella, JR ;
Merrill, AH ;
Wang, E ;
Jones, C .
FOOD AND CHEMICAL TOXICOLOGY, 1998, 36 (9-10) :791-+
[6]   Fumonisin B1, a mycotoxin contaminant of cereal grains, and inducer of apoptosis via the tumour necrosis factor pathway and caspase activation [J].
Ciacci-Zanella, JR ;
Jones, C .
FOOD AND CHEMICAL TOXICOLOGY, 1999, 37 (07) :703-712
[7]  
Declercq W, 1998, J IMMUNOL, V161, P390
[8]   GENERATION AND BIOLOGICAL CHARACTERIZATION OF MEMBRANE-BOUND, UNCLEAVABLE MURINE TUMOR-NECROSIS-FACTOR [J].
DECOSTER, E ;
VANHAESEBROECK, B ;
VANDENABEELE, P ;
GROOTEN, J ;
FIERS, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) :18473-18478
[9]  
Dugyala RR, 1998, J PHARMACOL EXP THER, V285, P317
[10]   Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B1 [J].
Enongene, EN ;
Sharma, RP ;
Bhandari, N ;
Voss, KA ;
Riley, RT .
FOOD AND CHEMICAL TOXICOLOGY, 2000, 38 (09) :793-799